Xenopus: An ideal system for chemical genetics

Genesis

Volumn 50, Issue 3, 2012, Pages 207-218

  Wheeler, Grant N ^a   Liu, Karen J ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chemical genetics; Forward and reverse screens; Small molecules; Xenopus

Indexed keywords

CHEMICAL GENETICS; GENETIC ENGINEERING; GENETIC MODEL; GENETIC SCREENING; IN VIVO STUDY; MOLECULAR MODEL; NONHUMAN; PHENOTYPE; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA TRANSLATION; SIGNAL NOISE RATIO; TRANSCRIPTION REGULATION; XENOPUS;

ANIMALS; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HIGH-THROUGHPUT SCREENING ASSAYS; PHARMACEUTICAL PREPARATIONS; SMALL MOLECULE LIBRARIES; XENOPUS;

ANURA;

EID: 84857998497     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.22009     Document Type: Review

References (74)

1. Adams DS, Levin M. 2006. Inverse drug screens: A rapid and inexpensive method for implicating molecular targets. Genesis 44: 530-540.
2. Adams DS, Robinson KR, Fukumoto T, Yuan S, Albertson RC, Yelick P, Kuo L, McSweeney M, Levin M. 2006. Early, H+-V-ATPase-dependent proton flux is necessary for consistent left-right patterning of nonmammalian vertebrates. Development 133: 1657-1671.
3. Almogy G, Nolan GP. 2009. Conditional protein stabilization via the small molecules Shld-1 and rapamycin increases the signal-to-noise ratio with tet-inducible gene expression. Biotechniques 46: 44-50.
4. Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ. 2006. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126: 995-1004.
5. Blackiston D, Adams DS, Lemire JM, Lobikin M, Levin M. 2011. Transmembrane potential of GlyCl-expressing instructor cells induces a neoplastic-like conversion of melanocytes via a serotonergic pathway. Dis Models Mech 4: 67-85.
6. Blackiston D, Shomrat T, Nicolas CL, Granata C, Levin M. 2010. A second-generation device for automated training and quantitative behavior analyses of molecularly tractable model organisms. PloS One 5: e14370.
7. Brändli A. 2004. Prospects for the Xenopus embryo model in therapeutics technologies. Chimia 58: 694-702.
8. Cambridge SB, Geissler D, Calegari F, Anastassiadis K, Hasan MT, Stewart AF, Huttner WB, Hagen V, Bonhoeffer T. 2009. Doxycycline-dependent photoactivated gene expression in eukaryotic systems. Nat Methods 6: 527-531.
9. Carneiro K, Donnet C, Rejtar T, Karger BL, Barisone GA, Diaz E, Kortagere S, Lemire JM, Levin M. 2011. Histone deacetylase activity is necessary for left-right patterning during vertebrate development. BMC Dev Biol 11: 29.
10. Chae J, Zimmerman LB, Grainger RM. 2002. Inducible control of tissue-specific transgene expression in Xenopus tropicalis transgenic lines. Mech Dev 117: 235-241.
11. Chang P, Coughlin M, Mitchison TJ. 2005. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat Cell Biol 7: 1133-1139.
12. Chen X, Ye H, Kuruvilla R, Ramanan N, Scangos KW, Zhang C, Johnson NM, England PM, Shokat KM, Ginty DD. 2005. A chemical-genetic approach to studying neurotrophin signaling. Neuron 46: 13-21.
13. Clark AJ, Bissinger P, Bullock DW, Damak S, Wallace R, Whitelaw CB, Yull F. 1994 Chromosomal position effects and the modulation of transgene expression. Reprod Fertil Dev 6: 589-598.
14. Dale L, Slack JM. 1987. Fate map for the 32-cell stage of Xenopus laevis. Development 99: 527-551.
15. Das B, Brown DD. 2004. Controlling transgene expression to study Xenopus laevis metamorphosis. Proc Natl Acad Sci USA 101: 4839-4842.
16. Davidson EH, Rast JP, Oliveri P, Ransick A, Calestani C, Yuh CH, Minokawa T, Amore G, Hinman V, Arenas-Mena C, Otim O, Brown CT, Livi CB, Lee PY, Revilla R, Rust AG, Pan Z, Schilstra MJ, Clarke PJ, Arnone MI, Rowen L, Cameron RA, McClay DR, Hood L, Bolouri H. 2002. A genomic regulatory network for development. Science 295: 1669-1678.
17. Deiters A, Garner RA, Lusic H, Govan JM, Dush M, Nascone-Yoder NM, Yoder JA. 2010. Photocaged morpholino oligomers for the light-regulation of gene function in zebrafish and Xenopus embryos. J Am Chem Soc 132: 15644-15650.
18. Dodd DW, Damjanovski S, Hudson RE. 2011. Peptide nucleic acid Pt(II) conjugates: A preliminary study of antisense effects in Xenopus laevis. Nucleosides Nucleotides Nucleic Acids 30: 257-263.
19. Dupre A, Boyer-Chatenet L, Sattler RM, Modi AP, Lee JH, Nicolette ML, Kopelovich L, Jasin M, Baer R, Paull TT, Gautier J. 2008. A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex. Nat Chem Biol 4: 119-125.
20. Dush MK, McIver AL, Parr MA, Young DD, Fisher J, Newman DR, Sannes PL, Hauck ML, Deiters A, Nascone-Yoder N. 2011. Heterotaxin: A TGF-beta signaling inhibitor identified in a multi-phenotype profiling screen in Xenopus embryos. Chem Biol 18: 252-263.
21. Fini JB, Le Mevel S, Turque N, Palmier K, Zalko D, Cravedi JP, Demeneix BA. 2007. An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ Sci Technol 41: 5908-5914.
22. Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, et al. 2002. Small-molecule modulators of Hedgehog signaling: Identification and characterization of smoothened agonists and antagonists. J Biol 1: 10.
23. Fukumoto T, Kema IP, Levin M. 2005. Serotonin signaling is a very early step in patterning of the left-right axis in chick and frog embryos. Curr Biol 15: 794-803.
24. Garcia-Morales C, Liu CH, Abu-Elmagd M, Hajihosseini MK, Wheeler GN. 2009. Frizzled-10 promotes sensory neuron development in Xenopus embryos. Dev Biol 335: 143-155.
25. Goda T, Abu-Daya A, Carruthers S, Clark MD, Stemple DL, Zimmerman LB. 2006. Genetic screens for mutations affecting development of Xenopus tropicalis. PLoS Genet 2: e91.
26. Grammer TC, Liu KJ, Mariani FV, Harland RM. 2000. Use of large-scale expression cloning screens in the Xenopus laevis tadpole to identify gene function. Dev Biol 228: 197-210.
27. Hanvey JC, Peffer NJ, Bisi JE, Thomson SA, Cadilla R, Josey JA, Ricca DJ, Hassman CF, Bonham MA, Au KG, et al. 1992. Antisense and antigene properties of peptide nucleic acids. Science 258: 1481-1485.
28. Hartley KO, Nutt SL, Amaya E. 2002. Targeted gene expression in transgenic Xenopus using the binary Gal4-UAS system. Proc Natl Acad Sci USA 99: 1377-1382.
29. Heasman J, Kofron M, Wylie C. 2000. Beta-catenin signaling activity dissected in the early Xenopus embryo: A novel antisense approach. Dev Biol 222: 124-134.
30. Horb ME, Thomsen GH. 1999. Tbx5 is essential for heart development. Development 126: 1739-1751.
31. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, Fazal A, Tomlinson R, Serluca F, Shao W, Cheng H, Shultz M, Rau C, Schirle M, Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
32. Kalin RE, Banziger-Tobler NE, Detmar M, Brandli AW. 2009. An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis. Blood 114: 1110-1122.
33. Kolm PJ, Sive HL. 1995. Efficient hormone-inducible protein function in Xenopus laevis. Dev Biol 171: 267-272.
34. Lennox KA, Sabel JL, Johnson MJ, Moreira BG, Fletcher CA, Rose SD, Behlke MA, Laikhter AL, Walder JA, Dagle JM. 2006. Characterization of modified antisense oligonucleotides in Xenopus laevis embryos. Oligonucleotides 16: 26-42.
35. Levin M, Buznikov GA, Lauder JM. 2006. Of minds and embryos: Left-right asymmetry and the serotonergic controls of preneural morphogenesis. Dev Neurosci 28: 171-185.
36. Liu J, Wu X, Mitchell B, Kintner C, Ding S, Schultz PG. 2005. A small-molecule agonist of the Wnt signaling pathway. Angew Chem 44: 1987-1990.
37. Liu KJ, Arron JR, Stankunas K, Crabtree GR, Longaker MT. 2007. Chemical rescue of cleft palate and midline defects in conditional GSK-3beta mice. Nature 446: 79-82.
38. Liu KJ, Gestwicki JE, Crabtree GR. 2006. Bringing small molecule regulation of protein activity to developmental systems. In: Sater A, Whitman M, editors. Analysis of Growth Factor Signalling in Embryos: CRC Press. p 369-394.
39. Longo M, Zanoncelli S, Della Torre P, Rosa F, Giusti A, Colombo P, Brughera M, Mazue G, Olliaro P. 2008. Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the frog embryo teratogenesis assay-xenopus (FETAX). Reprod Toxicol 25: 433-441.
40. Love NR, Thuret R, Chen Y, Ishibashi S, Sabherwal N, Paredes R, Alves-Silva J, Dorey K, Noble AM, Guille MJ, Sasai Y, Papalopulu N, Amaya E. 2011. pTransgenesis: a cross-species, modular transgenesis resource. Development 138: 5451-5458.
41. Lund E, Sheets MD, Imoden SB, Dahlberg JE. 2011. Limiting Ago protein restricts RNAi and microRNA biogenesis during early development in Xenopus laevis. Genes Dev 25: 1121-1131.
42. Meijer L, Skaltsounis AL, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, et al. 2003. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 10: 1255-1266.
43. Morckel AR, Lusic L, Farzana L, Yoder JA, Deiters A, Nascone-Yoder NM. 2012. A photoactivatable small-molecule inhibitor for light-controlled spatiotemporal regulation of Rho kinase in live embryos. Development 139: 437-442.
44. Nielsen TE, Schreiber SL. 2008. Towards the optimal screening collection: a synthesis strategy. Angew Chem 47: 48-56.
45. Nusslein-Volhard C, Wieschaus E. 1980. Mutations affecting segment number and polarity in Drosophila. Nature 287: 795-801.
46. Obika S, Hemamayi R, Masuda T, Sugimoto T, Nakagawa S, Mayumi T, Imanishi T. 2001 Inhibition of ICAM-1 gene expression by antisense 2′, 4′-BNA oligonucleotides. Nucleic Acids Res Suppl 1: 145-146.
47. Paddison PJ, Caudy AA, Hannon GJ. 2002. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci USA 99: 1443-1448.
48. Page-McCaw A, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
49. Peterson JR, Lebensohn AM, Pelish HE, Kirschner MW. 2006. Biochemical suppression of small-molecule inhibitors: A strategy to identify inhibitor targets and signaling pathway components. Chem Biol 13: 443-452.
50. Peterson JR, Lokey RS, Mitchison TJ, Kirschner MW. 2001. A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc Natl Acad Sci USA 98: 10624-10629.
51. Pownall ME, Welm BE, Freeman KW, Spencer DM, Rosen JM, Isaacs HV. 2003. An inducible system for the study of FGF signalling in early amphibian development. Dev Biol 256: 89-99.
52. Rankin SA, Zorn AM, Buchholz DR. 2011. New doxycycline-inducible transgenic lines in Xenopus. Dev Dyn Off Publication Am Assoc Anatom 240: 1467-1474.
53. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434: 843-850.
54. Richards SM, Cole SE. 2006. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 15: 647-656.
55. Rones MS, McLaughlin KA, Raffin M, Mercola M. 2000. Serrate and notch specify cell fates in the heart field by suppressing cardiomyogenesis. Development 127: 3865-3876.
56. Schneider PN, Olthoff JT, Matthews AJ, Houston DW. 2011. Use of fully modified 2′-O-methyl antisense oligos for loss-of-function studies in vertebrate embryos. Genesis 49: 117-123.
57. Shestopalov IA, Sinha S, Chen JK. 2007. Light-controlled gene silencing in zebrafish embryos. Nat Chem Biol 3: 650-651.
58. Stankunas K, Bayle JH, Gestwicki JE, Lin YM, Wandless TJ, Crabtree GR. 2003. Conditional protein alleles using knockin mice and a chemical inducer of dimerization. Mol Cell 12: 1615-1624.
59. Tomlinson ML, Fidock M, Field RA, Wheeler GN. 2009a. A developmental chemical genomic screen in Xenopus. Mol Biosyst 5: 376-384.
60. Tomlinson ML, Field RA, Wheeler GN. 2005. Xenopus as a model organism in developmental chemical genetic screens. Mol Biosyst 1: 223-228.
61. Tomlinson ML, Garcia-Morales C, Abu-Elmagd M, Wheeler GN. 2008. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development. Mech Dev 125: 1059-1070.
62. Tomlinson ML, Guan P, Morris RJ, Fidock MD, Rejzek M, Garcia-Morales C, Field RA, Wheeler GN. 2009b. A chemical genomic approach identifies matrix metalloproteinases as playing an essential and specific role in Xenopus melanophore migration. Chem Biol 16: 93-104.
63. Tomlinson ML, Hendry A, Wheeler GN. 2012. Chemical genetics and drug discovery in Xenopus. Methods Mol Biol, in press.
64. Van Raay TJ, Vetter ML. 2004. Wnt/frizzled signaling during vertebrate retinal development. Dev Neurosci 26: 352-358.
65. Vandenberg LN, Morrie RD, Adams DS. 2011. V-ATPase-dependent ectodermal voltage and pH regionalization are required for craniofacial morphogenesis. Dev Dyn Off Publication Am Assoc Anatom 240: 1889-1904.
66. Verma R, Peters NR, D'Onofrio M, Tochtrop GP, Sakamoto KM, Varadan R, Zhang M, Coffino P, Fushman D, Deshaies RJ, King RW. 2004. Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain. Science 306: 117-120.
67. Wahlestedt C, Salmi P, Good L, Kela J, Johnsson T, Hokfelt T, Broberger C, Porreca F, Lai J, Ren K, et al. 2000. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA 97: 5633-5638.
68. Walsh DP, Chang YT. 2006. Chemical genetics. Chem Rev 106: 2476-2530.
69. Wheeler GN, Brandli AW. 2009. Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus. Dev Dyn Off Publication Am Assoc Anatom 238: 1287-1308.
70. Wheeler GN, Field RA, Tomlinson ML. 2011. Phenotypic screens with model organisms. In: Fu H, editor. Chemical Genomics. New York: Cambridge University Press. p 121-136.
71. White RM, Cech J, Ratanasirintrawoot S, Lin CY, Rahl PB, Burke CJ, Langdon E, Tomlinson ML, Mosher J, Kaufman C, Chen F, Long HK, Kramer M, Datta S, Neuberg D, Granter S, Young RA, Morrison S, Wheeler GN, Zon LI. 2011. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471: 518-522.
72. Wignall SM, Gray NS, Chang YT, Juarez L, Jacob R, Burlingame A, Schultz PG, Heald R. 2004. Identification of a novel protein regulating microtubule stability through a chemical approach. Chem Biol 11: 135-146.
73. Woolf TM, Jennings CG, Rebagliati M, Melton DA. 1990. The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos. Nucleic Acids Res 18: 1763-1769.
74. Yang J, Symes K, Mercola M, Schreiber SL. 1998. Small-molecule control of insulin and PDGF receptor signaling and the role of membrane attachment. Curr Biol 8: 11-18.